Natriumchloride Kabipac Fresenius Kabi (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchloride Kabipac, is an electrolyte presented as an injection solution for intravenous use. It is employed to restore extracellular sodium concentration and osmolarity, supporting fluid replacement, electrolyte balance and treatment of hypovolemia in hospital patients.

GNH USA supplies Natriumchloride Kabipac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumchloride Kabipac is used in clinical settings to manage conditions involving fluid and electrolyte disturbances.

- Fluid replacement: restores intravascular volume in patients with dehydration or blood loss. - Electrolyte balance: corrects sodium deficits and maintains osmotic equilibrium. - Hypovolemia: supports circulatory volume in shock or severe fluid loss. - Dehydration: rehydrates patients unable to maintain adequate oral intake.

Adverse reactions may occur with intravenous sodium chloride administration.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Infusion site irritation or phlebitis. - Mild peripheral edema. - Nausea or vomiting. - Headache. - Transient fever.

Serious or Rare Side Effects: - Severe hypernatremia leading to neurological impairment. - Pulmonary edema in patients with compromised cardiac function. - Anaphylactic or severe allergic reactions. - Cardiac arrhythmias due to electrolyte imbalance. - Seizures associated with extreme hyperosmolarity. - Metabolic acidosis in rare cases.

When using Natriumchloride Kabipac, clinicians should observe several safety measures.

- Assess baseline serum sodium: verify patient electrolyte status before infusion. - Monitor fluid balance: track input/output and weight changes during therapy. - Adjust infusion rate in cardiac or renal impairment: avoid fluid overload. - Use aseptic technique: prevent contamination of the IV line. - Avoid concurrent hypertonic solutions: reduce risk of hypernatremia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Intravenous sodium chloride can interact with other medications and solutions.

Major Interactions (Avoid): - Co‑administration with other hypertonic sodium solutions: may cause severe hypernatremia. - Concurrent use of high‑dose potassium chloride: can exacerbate electrolyte disturbances. - Simultaneous infusion of hyperosmolar dextrose solutions: increases risk of osmotic shifts.

Moderate Interactions (Monitor Closely): - Loop diuretics: may amplify sodium loss, requiring careful monitoring. - Lithium therapy: sodium levels influence lithium clearance, risking toxicity. - NSAIDs or ACE inhibitors: can affect renal function and fluid balance.